1 Death of baby (up to discharge) |
1 |
270 |
Risk Ratio (M‐H, Random, 95% CI) |
0.47 [0.20, 1.11] |
1.1 < 32‐34 weeks gestation |
1 |
270 |
Risk Ratio (M‐H, Random, 95% CI) |
0.47 [0.20, 1.11] |
1.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
1.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
2 Death or neurodevelopmental impairment at age two to three years |
1 |
218 |
Risk Ratio (M‐H, Random, 95% CI) |
0.61 [0.39, 0.96] |
2.1 < 32‐34 weeks gestation |
1 |
218 |
Risk Ratio (M‐H, Random, 95% CI) |
0.61 [0.39, 0.96] |
2.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
2.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
3 Severe intraventricular haemorrhage (IVH grades 3, 4) |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.84 [0.29, 2.45] |
3.1 < 32‐34 weeks gestation |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.84 [0.29, 2.45] |
3.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
3.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
4 Intraventricular haemorrhage (IVH, all grades) |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.90 [0.64, 1.26] |
4.1 < 32‐34 weeks gestation |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.90 [0.64, 1.26] |
4.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
4.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
5 Periventricular leukomalacia (PVL) |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.86 [0.32, 2.31] |
5.1 < 32‐34 weeks gestation |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.86 [0.32, 2.31] |
5.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
5.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
6 Chronic lung disease (CLD) ‐ oxygen supplement at 36 weeks (corrected for gestation) |
1 |
249 |
Risk Ratio (M‐H, Random, 95% CI) |
0.95 [0.66, 1.37] |
6.1 < 32‐34 weeks gestation |
1 |
249 |
Risk Ratio (M‐H, Random, 95% CI) |
0.95 [0.66, 1.37] |
6.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
6.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
7 Maternal blood loss of 500 mL or greater |
1 |
254 |
Risk Ratio (M‐H, Random, 95% CI) |
0.94 [0.72, 1.22] |
7.1 < 32‐34 weeks gestation |
1 |
254 |
Risk Ratio (M‐H, Random, 95% CI) |
0.94 [0.72, 1.22] |
7.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
7.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
8 Intraventricular haemorrhage (IVH, grades 1 & 2) |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.91 [0.63, 1.33] |
8.1 < 32‐34 weeks gestation |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.91 [0.63, 1.33] |
8.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
8.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
9 Necrotising enterocolitis (NEC) confirmed by X‐ray or laparotomy) |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
1.58 [0.53, 4.69] |
9.1 < 32‐34 weeks gestation |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
1.58 [0.53, 4.69] |
9.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
9.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
10 Respiratory Distress Syndrome (RDS) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
10.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
10.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
10.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
11 Respiratory support (ventilator or CPAP) |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.96 [0.84, 1.09] |
11.1 < 32‐34 weeks gestation |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.96 [0.84, 1.09] |
11.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
11.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
12 Duration of respiratory support |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
12.1 < 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
12.2 > 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
12.3 Mixed gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
13 Surfactant treatment (for severe RDS) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
13.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
13.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
13.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
14 Treatment for Patent Ductus Arteriosus (PDA) (medical and/or surgical) |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.99 [0.56, 1.74] |
14.1 < 32‐34 weeks gestation |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.99 [0.56, 1.74] |
14.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
14.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
15 Treatment for Retinopathy of Prematurity (RoP) |
1 |
249 |
Risk Ratio (M‐H, Random, 95% CI) |
0.93 [0.28, 3.13] |
15.1 < 32‐34 weeks gestation |
1 |
249 |
Risk Ratio (M‐H, Random, 95% CI) |
0.93 [0.28, 3.13] |
15.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
15.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
16 Hyperbilirubinemia (treated by phototherapy) |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
1.01 [0.94, 1.09] |
16.1 < 32‐34 weeks gestation |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
1.01 [0.94, 1.09] |
16.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
16.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
17 Inotropics for low blood pressure |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
17.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
17.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
17.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
18 Low Apgar as defined by trialists (generally < 8 at 5 mins) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
18.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
18.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
18.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
19 Blood transfusion in infant |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.91 [0.71, 1.17] |
19.1 < 32‐34 weeks gestation |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.91 [0.71, 1.17] |
19.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
19.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
20 Volume of blood transfused (mL) |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
20.1 < 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
20.2 > 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
20.3 Mixed gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
21 Late sepsis (after 3 days or as defined by trialists) |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.89 [0.72, 1.09] |
21.1 < 32‐34 weeks gestation |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.89 [0.72, 1.09] |
21.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
21.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
22 Hydrocephalus |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.99 [0.14, 6.89] |
22.1 < 32‐34 weeks gestation |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
0.99 [0.14, 6.89] |
22.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
22.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
23 Temperature < 36.0oC within 1 hour of birth |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
1.20 [0.61, 2.33] |
23.1 < 32‐34 weeks gestation |
1 |
266 |
Risk Ratio (M‐H, Random, 95% CI) |
1.20 [0.61, 2.33] |
23.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
23.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
24 Hb within 1st 24 hour of birth (g/dL) |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
24.1 < 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
24.2 > 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
24.3 Mixed gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
25 Mean arterial blood pressure (subgrouped by time after birth) |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
25.1 < 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
25.2 Mixed gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
25.3 > 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
26 Length of infant stay in NICU |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
26.1 < 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
26.2 > 32‐34 weeks gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
26.3 Mixed gestation |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
27 Home oxygen |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
27.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
27.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
27.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
28 Neurodevelopmental impairment at age two to three years |
1 |
218 |
Risk Ratio (M‐H, Random, 95% CI) |
0.75 [0.41, 1.39] |
28.1 < 32‐34 weeks gestation |
1 |
218 |
Risk Ratio (M‐H, Random, 95% CI) |
0.75 [0.41, 1.39] |
28.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
28.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
29 Severe visual impairment |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
29.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
29.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
29.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
30 Cerebral palsy (CP) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
30.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
30.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
30.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
31 Manual removal of placenta (denominator = vaginal births) |
1 |
105 |
Risk Ratio (M‐H, Random, 95% CI) |
0.99 [0.32, 3.04] |
31.1 < 32‐34 weeks gestation |
1 |
105 |
Risk Ratio (M‐H, Random, 95% CI) |
0.99 [0.32, 3.04] |
31.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
31.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
32 Prolonged third stage (>30 minutes) (denominator = vaginal births) |
1 |
105 |
Risk Ratio (M‐H, Random, 95% CI) |
0.79 [0.24, 2.64] |
32.1 < 32‐34 weeks gestation |
1 |
105 |
Risk Ratio (M‐H, Random, 95% CI) |
0.79 [0.24, 2.64] |
32.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
32.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
33 Blood transfusion for mother |
1 |
254 |
Risk Ratio (M‐H, Random, 95% CI) |
1.59 [0.39, 6.51] |
33.1 < 32‐34 weeks gestation |
1 |
254 |
Risk Ratio (M‐H, Random, 95% CI) |
1.59 [0.39, 6.51] |
33.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
33.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
34 Postpartum infection in mother |
1 |
254 |
Risk Ratio (M‐H, Random, 95% CI) |
1.12 [0.73, 1.72] |
34.1 < 32‐34 weeks gestation |
1 |
254 |
Risk Ratio (M‐H, Random, 95% CI) |
1.12 [0.73, 1.72] |
34.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
34.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
35 Rhesus isoimmunisation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
35.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
35.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
35.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
36 Psychological well being in mother |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
36.1 < 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
36.2 > 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
36.3 Mixed gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
37 Bonding |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
37.1 < 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
37.2 > 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
37.3 Mixed gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
38 Breastfeeding initiation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
38.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
38.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
38.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
39 Fully breastfed or mixed feeding at infant discharge |
1 |
248 |
Risk Ratio (M‐H, Random, 95% CI) |
0.98 [0.79, 1.22] |
39.1 < 32‐34 weeks gestation |
1 |
248 |
Risk Ratio (M‐H, Random, 95% CI) |
0.98 [0.79, 1.22] |
39.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
39.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
40 Maternal anxiety |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
40.1 < 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
40.2 > 32‐34 weeks gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
40.3 Mixed gestation |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
41 Mothers' views |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
41.1 < 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
41.2 > 32‐34 weeks gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
41.3 Mixed gestation |
0 |
0 |
Std. Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |